{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Colchicine", "query": { "condition": "Colchicine" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 62, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Colchicine&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T05:01:53.802Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00983905", "title": "Drug-Drug Interaction Study of Colchicine and Theophylline", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pharmacokinetics" ], "interventions": [ { "name": "Theophylline", "type": "DRUG" }, { "name": "Colchicine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mutual Pharmaceutical Company, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 30, "start_date": "2008-08", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2010-03-02", "last_synced_at": "2026-05-22T05:01:53.802Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00983905" }, { "nct_id": "NCT04500665", "title": "Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Kidney Diseases" ], "interventions": [ { "name": "Colchicine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "21 Years to 80 Years" }, "enrollment_count": 20, "start_date": "2021-11-01", "completion_date": "2026-11-11", "has_results": false, "last_update_posted_date": "2025-09-23", "last_synced_at": "2026-05-22T05:01:53.802Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04500665" }, { "nct_id": "NCT03575572", "title": "Colchicine in Postoperative Fontan Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Single-ventricle", "Heart Diseases" ], "interventions": [ { "name": "Colchicine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "20 Months", "maximum_age": "5 Years", "sex": "ALL", "summary": "20 Months to 5 Years" }, "enrollment_count": 11, "start_date": "2018-08-29", "completion_date": "2021-01-13", "has_results": true, "last_update_posted_date": "2022-05-09", "last_synced_at": "2026-05-22T05:01:53.802Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT03575572" }, { "nct_id": "NCT00983372", "title": "Drug-Drug Interaction Study Between Colchicine and Diltiazem ER", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy; Adult; Volunteer; Colchicine; Pharmacokinetics; Diltiazem; Cytochrome p450 3A4; P-glycoprotein" ], "interventions": [ { "name": "Colchicine", "type": "DRUG" }, { "name": "Diltiazem ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mutual Pharmaceutical Company, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 24, "start_date": "2008-08", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2009-10-15", "last_synced_at": "2026-05-22T05:01:53.802Z", "location_count": 1, "location_summary": "Fargo, North Dakota", "locations": [ { "city": "Fargo", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00983372" }, { "nct_id": "NCT06286423", "title": "Colchicine in Acutely Decompensated HFREF", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Heart Failure", "Decompensated Heart Failure", "Heart Failure With Reduced Ejection Fraction" ], "interventions": [ { "name": "Colchicine 0.6 mg", "type": "DRUG" }, { "name": "Control/Placebo group", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2024-06", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2024-05-08", "last_synced_at": "2026-05-22T05:01:53.802Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06286423" }, { "nct_id": "NCT01080131", "title": "Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicines Including a 12 Week Extension and a 1 Year Open-label Extension Study.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Gout" ], "interventions": [ { "name": "Canakinumab 150 mg", "type": "DRUG" }, { "name": "Triamcinolone acetonide 40 mg", "type": "DRUG" }, { "name": "Placebo to canakinumab", "type": "DRUG" }, { "name": "Placebo to triamcinolone acetonide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 226, "start_date": "2010-03", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2014-01-30", "last_synced_at": "2026-05-22T05:01:53.802Z", "location_count": 96, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Foley, Alabama + 81 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Foley", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01080131" }, { "nct_id": "NCT04774159", "title": "Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Peripheral Arterial Disease", "Atherosclerosis of Extremities", "Inflammation" ], "interventions": [ { "name": "Colchicine 0.5 MG Oral Tablet", "type": "DRUG" }, { "name": "Colchicine-Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Population Health Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6150, "start_date": "2021-05-06", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2026-03-24", "last_synced_at": "2026-05-22T05:01:53.802Z", "location_count": 19, "location_summary": "New Haven, Connecticut • Gainesville, Florida • Tampa, Florida + 14 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT04774159" }, { "nct_id": "NCT02083510", "title": "Apolipoprotein CIII Reduction Via Colchicine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Hypertriglyceridemia", "Gout", "Pericarditis" ], "interventions": [ { "name": "Colchicine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Scripps Translational Science Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2014-02", "completion_date": "2014-05", "has_results": false, "last_update_posted_date": "2014-05-30", "last_synced_at": "2026-05-22T05:01:53.802Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02083510" }, { "nct_id": "NCT00983242", "title": "Drug-Drug Interaction Between Colchicine and Verapamil ER", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pharmacokinetics" ], "interventions": [ { "name": "Colchicine", "type": "DRUG" }, { "name": "Verapamil HCl ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mutual Pharmaceutical Company, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 24, "start_date": "2008-09", "completion_date": "2008-10", "has_results": true, "last_update_posted_date": "2009-10-15", "last_synced_at": "2026-05-22T05:01:53.802Z", "location_count": 1, "location_summary": "East Grand Forks, Minnesota", "locations": [ { "city": "East Grand Forks", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00983242" }, { "nct_id": "NCT03874338", "title": "CLEAR SYNERGY Neutrophil Substudy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Neutrophils.Hypersegmented | Bld-Ser-Plas", "STEMI - ST Elevation Myocardial Infarction" ], "interventions": [ { "name": "Colchicine Pill", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": "110 Years", "sex": "ALL", "summary": "19 Years to 110 Years" }, "enrollment_count": 322, "start_date": "2019-03-04", "completion_date": "2024-08-09", "has_results": false, "last_update_posted_date": "2024-09-19", "last_synced_at": "2026-05-22T05:01:53.802Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03874338" } ] }